196
Participants
Start Date
December 20, 2017
Primary Completion Date
February 22, 2019
Study Completion Date
February 22, 2019
TRC101
Oral suspension
Placebo
Oral suspension
Investigative Site 95, Atlanta
Investigative Site 59, Hialeah
Investigative Site 93, Hollywood
Investigative Site 92, Lauderdale Lakes
Investigative Site 52, San Antonio
Investigative Site 55, Phoenix
Investigative Site 91, Los Angeles
Investigative Site 11, Sofia
Investigative Site 31, Tbilisi
Investigative Site 32, Tbilisi
Investigative Site 33, Tbilisi
Investigative Site 34, Tbilisi
Investigative Site 35, Tbilisi
Investigative Site 36, Tbilisi
Investigative Site 37, Tbilisi
Investigative Site 41, Budapest
Investigative Site 46, Budapest
Investigative Site 49, Hódmezővásárhely
Investigative Site 44, Kistarcsa
Investigative Site 61, Vršac
Investigative Site 72, Jesenice
Investigative Site 71, Maribor
Investigative Site 81, Kharkiv
Investigative Site 83, Kharkiv
Investigative Site 87, Kharkiv
Investigative Site 88, Kharkiv
Investigative Site 84, Kyiv
Investigative Site 85, Kyiv
Investigative Site 86, Kyiv
Tricida, Inc.
INDUSTRY